Wolfgang Schreiner

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Knee Osteoarthritis

Electronic Health Record

Molecular Dynamics

Top Venues

Journal of personalized medicine

BMC bioinformatics

Histochemistry and cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Kenn, Rudolf Karch, Christian F Singer, Georg Dorffner, Wolfgang Schreiner
Flexible Risk Evidence Combination Rules in Breast Cancer Precision Therapy. Journal of personalized medicine 13 (1) (2023)
Michael Kenn, Rudolf Karch, Christian F Singer, Georg Dorffner, Wolfgang Schreiner
Flexible Risk Evidence Combination Rules in Breast Cancer Precision Therapy. Journal of personalized medicine 13 (1) (2023)
Michael Kenn, Rudolf Karch, Christian F Singer, Georg Dorffner, Wolfgang Schreiner
Flexible Risk Evidence Combination Rules in Breast Cancer Precision Therapy. Journal of personalized medicine 13 (1) (2023)
Michael Kenn, Rudolf Karch, Dan Cacsire Castillo-Tong, Christian F Singer, Heinz Kölbl, Wolfgang Schreiner
Decision Theory versus Conventional Statistics for Personalized Therapy of Breast Cancer. Journal of personalized medicine 12 (4) (2022)
Katharina M Pichler, Anita Fischer, Jürgen Alphonsus, Catharina Chiari, Sebastian Schmidt, Michael Kenn, Wolfgang Schreiner, Daniela Weinmann, Mario Rothbauer, Reinhard Windhager, Hans-Joachim Gabius, Stefan Toegel
Galectin network in osteoarthritis: galectin-4 programs a pathogenic signature of gene and effector expression in human chondrocytes in vitro. Histochemistry and cell biology (2021)
Elisabeth S Gruber, Georg Oberhuber, Peter Birner, Michaela Schlederer, Michael Kenn, Wolfgang Schreiner, Gerd Jomrich, Sebastian F Schoppmann, Michael Gnant, William Tse, Lukas Kenner
Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357. Cells 9 (12) (2020)
Bernhard Roither, Chris Oostenbrink, Wolfgang Schreiner
Molecular dynamics of the immune checkpoint programmed cell death protein I, PD-1: conformational changes of the BC-loop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab. BMC bioinformatics 21 (Suppl 17) (2020)
Bernhard Roither, Chris Oostenbrink, Georg Pfeiler, Heinz Kölbl, Wolfgang Schreiner
Pembrolizumab Induces an Unexpected Conformational Change in the CC'-loop of PD-1. Cancers 13 (1) (2020)
Michael Kenn, Dan Cacsire Castillo-Tong, Christian F Singer, Michael Cibena, Heinz Kölbl, Wolfgang Schreiner
Microarray Normalization Revisited for Reproducible Breast Cancer Biomarkers. BioMed research international 2020 (2020)
Rudolf Karch, Claudia Stocsits, Nevena Ilieva, Wolfgang Schreiner
Intramolecular Domain Movements of Free and Bound pMHC and TCR Proteins: A Molecular Dynamics Simulation Study. Cells 8 (7) (2019)
Michael Kenn, Dan Cacsire Castillo-Tong, Christian F Singer, Michael Cibena, Heinz Kölbl, Wolfgang Schreiner
Co-expressed genes enhance precision of receptor status identification in breast cancer patients. Breast cancer research and treatment 172 (2) (2018)